ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Erelzi 50 mg/1 ml, Injektionslösung in einer Fertigspritze - 4
66175007 Sandoz Pharmaceuticals AG
Erelzi 50 mg/1 ml, Injektionslösung in einer Fertigspritze18.05.2018
  18.05.2018
Etanercept (L04AB01) 
WHO-DDD 
07.15.4
07.15. 
B  
No 
IP 
PR  
k.A.PR
  
7680661750075Biotechnologika
  
Composition
etanerceptum 50 mg, acidum citricum, natrii citras dihydricus, natrii chloridum, saccharum, lysini hydrochloridum, natrii hydroxidum aut acidum hydrochloridum 25 per centum, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 3.76 mg.
Packungsbestandteile
Injection solution in prefilled syringe 
  
 
Active AgentDose
Etanercept50 mg/ml
BAG: Active AgentDose
Etanercept50 mg
 
Inactive agentsDose
Citric Acid 
Lysine Hydrochloride 
Sodium Chloride 
Natrii Citras Dihydricus 
Natrii Hydroxidum aut Acidum Hydrochloridum25
Per Centum 
Saccharum 
 
Source
Data was imported : 05.09.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home